Non-alcoholic steatohepatitis: definitions and pathogenesis (Q35020857)

5 August 2017

1 reference

title

Non-alcoholic steatohepatitis: definitions and pathogenesis (English)

1 reference

non-alcoholic steatohepatitis

5 August 2017

0 references

1 reference

Day CP

1

1 reference

PubMed ID

12472967

5 August 2017

Saksena S

series ordinal

2

1 reference

5 August 2017

1 December 2002

1 reference

Journal of Gastroenterology and Hepatology

5 August 2017

1 reference

5 August 2017

17 Suppl 3

1 reference

5 August 2017

S377-84

1 reference

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

5 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

21 January 2018

Mallory bodies revisited

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

Alcoholic liver disease: new insights into mechanisms and preventative strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

Lipotoxic heart disease in obese rats: implications for human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

Resistin, central obesity, and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

Does central obesity reflect "Cushing's disease of the omentum"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

Turning down insulin signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

Inhibition of target cell mitochondrial electron transfer by tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S3.31.X

10.1046/J.1440-1746.17.S3.31.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12472967